DNA vaccine encoding, page-22

Daniel no need to speculate I already asked that question about 6 months ago.
Their response was that they had put a stop to their current path as the thinking was that they may be on the wrong path and putting money into a treatment that may not give the company the best bang for the buck ( my words), and only target an outcome that was deemed appropriate to move forward and at that point Head and Neck Cancer was mentioned. So this midstream change in focus was always going to in the short term, delay the time line of HPV, as to partnerships I do remember Wayne in the AGM stating ongoing
talks and stating it is a long process however it was progressing. GLTA